Tandem Diabetes Care, Inc.
NASDAQ:TNDMMedical - Devices
Healthcare
$16.80 +1.53%
+$0.24 today
- Market cap
- $1.17B
- Beta
- 1.57
- P/E (TTM)
- -11.3
- EPS (TTM)
- -$1.38
52W Low $9.98High $29.65
Volume 2.30M
Average 2.43M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$9.72M
FY 2025 · Annual
Investing Cash Flow
$72.88M
FY 2025 · Annual
Financing Cash Flow
-$43.37M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 15.57M | (94.59M) | (222.61M) | (96.03M) | (204.71M) |
| Depreciation & Amortization | 13.85M | 14.33M | 15.72M | 16.61M | 13.84M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 60.75M | 84.92M | 88.08M | 101.38M | 92.38M |
| Change in Working Capital | 14.37M | (4.65M) | (17.69M) | (11.78M) | (23.04M) |
| Accounts Receivables | (30.98M) | (7.83M) | 4.28M | (20.8M) | (56.81M) |
| Inventory | (4.95M) | (42.45M) | (46.05M) | 5.81M | 24.82M |
| Accounts Payables | 10.28M | 24.49M | (4.86M) | (2.39M) | 2.23M |
| Other Working Capital | 40.03M | 21.14M | 28.96M | 5.6M | 6.73M |
| Other Non-Cash Items | 6.82M | 50.46M | 104.7M | 14.04M | 111.81M |
| Operating Cash Flow | 111.36M | 50.46M | (31.81M) | 24.23M | (9.72M) |
| Capital Expenditures | (23.51M) | (34.1M) | (26.8M) | (19.23M) | (19.95M) |
| Acquisitions (Net) | 0 | (25.72M) | (69.5M) | 0 | 0 |
| Purchases of Investments | (733.39M) | (467.65M) | (535.66M) | (264.31M) | (85.66M) |
| Sales of Investments | 570.02M | 569.49M | 546.22M | 306.46M | 257.07M |
| Other Investing Activities | (9.33M) | (8.86M) | 0 | (46.4M) | (78.59M) |
| Investing Cash Flow | (186.88M) | 33.17M | (85.74M) | (23.48M) | 72.88M |
| Debt Repayment | 0 | 0 | 0 | 44.91M | (40.76M) |
| Common Stock Issued | 0 | 17.55M | 0 | (6.73M) | (2.61M) |
| Common Stock Repurchased | 0 | 0 | 0 | (30M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 51.93M | (675K) | 4.11M | 183K | 0 |
| Financing Cash Flow | 51.93M | 16.88M | 4.11M | 8.37M | (43.37M) |
| Effect of Forex Changes | 153K | 827K | (212K) | 1.26M | 1.61M |
| Net Change in Cash | (23.43M) | 101.34M | (113.65M) | 10.37M | 21.4M |
| Free Cash Flow | 87.85M | 16.37M | (58.61M) | 4.99M | (29.67M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$204.7M
+ D&A$13.8M
+ Stock-Based Comp$92.4M
+ Deferred Tax$0
- Working Capital-$23.0M
+ Other Non-Cash$111.8M
= Operating Cash Flow-$9.7M
- Capex-$19.9M
= Free Cash Flow-$29.7M
Analysis
FY2025 free cash flow is -$29.7M. FCF conversion is 14.5% of net income. Operating cash flow was -$9.7M, with capex of -$19.9M. The largest bridge item is Other Non-Cash at $111.8M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 13, 2026 | |
| SC 13G | SC 13G filing | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 29, 2026 |
Does TNDM generate free cash flow?
Tandem Diabetes Care, Inc. (TNDM) generated -$29.67M of free cash flow in fiscal 2025.
How much operating cash flow does TNDM produce?
Operating cash flow was -$9.72M, before capital expenditures of $19.95M.
Continue the stock analysis
Jump to another research area for this company.